China tightens fentanyl-precursor exports as US indicts PRC firms supplying Mexican cartels
Beijing schedules all INCB-listed precursors and adds export controls; Washington indicts six PRC nationals over chemicals sent to a Gulf Cartel network
Summary
Fentanyl-precursor controls tightened on both sides of the Pacific through 2025-26. By June 2025 China had scheduled every precursor listed by the US-cited INCB, added nitazene-class opioids a month later, and in November 2025 placed export controls on 13 precursor chemicals bound for North America, with three more added after the May 2026 Trump-Beijing visit. The Dea assesses Chinese suppliers have shifted from finished fentanyl to precursor export to Mexican cartels, and reports some Mexican "cooks" now struggle to source key inputs. In March 2026 the US indicted six PRC nationals and two pharmaceutical firms for supplying a Gulf Cartel network. Analysts (Insight Crime) warn "designer" precursors remain outside the scheduled list.
By the numbers
- 7, fentanyl precursors under INCB international control as of May 2026.
- 13 + 3, precursor chemicals under PRC export controls to North America (Nov 2025; +3 after May 2026).
- 6 PRC nationals + 2 firms, indicted March 2026 over supply to a Gulf Cartel network.
- 183, fentanyl-related substances with no legitimate use, per INCB (April 2026).
Why it matters
Precursor chemistry is the choke point of the synthetic-opioid trade: cartels manufacture, but China supplies the inputs. Scheduling and export controls are now a live bargaining chip in US-China trade talks, while the gap on uncontrolled analogues means enforcement perpetually chases the chemistry.
What to watch
- Whether designer/analogue precursors get added faster than chemists substitute them.
- Mexican production response, shortages, price moves, alternative sourcing (India).
- Whether precursor controls become a formal US-China trade-deal condition.